CJC-1295 with DAC

CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic analog of growth hormone–releasing hormone (GHRH), designed to extend the biological half-life of the peptide in experimental models. By binding to albumin in the bloodstream, the DAC modification allows researchers to observe prolonged stimulation of endogenous growth hormone (GH) release over several days, as opposed to the more transient pulse seen with non-DAC versions.

$33.00

Buy Now

Reliable shipping

100% Satisfaction

Money Back Grantee

Easy
Returns

Description

Disclaimer:For research use only. Not for human or veterinary use.

 

That matches:

Peptide sequence: H‑Tyr‑D‑Ala²‑Asp‑Ala‑Ile‑Phe‑Thr‑Gln⁸‑Ser‑Tyr‑Arg‑Lys‑Val‑Leu‑Ala¹⁵‑Gln‑Leu‑Ser‑Ala‑Arg‑Lys‑Leu‑Leu‑Gln‑Asp‑Ile‑Leu²⁷‑Ser‑Arg‑(N^ɛ‑maleimidopropionyl‑Lys³⁰)‑NH₂ (CJC‑1295 with DAC) WikipediaPMC+8Wikipedia+8PubMed+8

Molecular formula: C₁₆₅H₂₆₉N₄₇O₄₆

Molecular weight: >3500 Da (extended)

PubChem CID: 56841945 Wikipedia

Correct CAS: 446262‑90‑4

CJC-1295 with DAC is frequently studied in the context of growth hormone regulation, tissue repair, and metabolic signaling. Its extended duration allows for fewer administrations in long-term investigative models, offering distinct advantages in chronic dosing studies.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 with DAC”

Your email address will not be published. Required fields are marked *

Related Products

Subscribe for exclusive offers, first access to sales and new releases

Must be 21 years or older and I am a professional researcher and understand
how to properly handle and use these products for research purposes only. I acknowledge
these products are not intended for human consumption.